Insider · CIK 0001563572

CHASE WILLIAM J

Reports to the SEC for 3 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001563572

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	GRALGRAIL, Inc.A Award	Director	AAward	+276 sh	$74.36	+$20.5K	42,978
2026-06-18	GRALGRAIL, Inc.A Award	Director	AAward	+5,491 sh	$63.74	+$350K	42,702
2026-06-09	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+9,200 sh	—	—	143,893
2026-06-09	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,300
2026-04-15	GRALGRAIL, Inc.A Award	Director	AAward	+408 sh	$49.79	+$20.3K	37,211
2026-01-15	GRALGRAIL, Inc.A Award	Director	AAward	+213 sh	$97.44	+$20.8K	36,803
2025-10-15	GRALGRAIL, Inc.A Award	Director	AAward	+275 sh	$75.52	+$20.8K	36,590
2025-08-20	NTLAIntellia Therapeutics, Inc.P Purchase	Director	PPurchase	+100K sh	$10.03	+$1M	134,693
2025-07-15	GRALGRAIL, Inc.A Award	Director	AAward	+533 sh	$38.53	+$20.5K	36,315
2025-06-11	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,450
2025-06-11	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+8,000 sh	—	—	34,693
2025-05-29	GRALGRAIL, Inc.A Award	Director	AAward	+6,082 sh	$41.10	+$250K	35,782
2025-04-15	GRALGRAIL, Inc.A Award	Director	AAward	+784 sh	$25.94	+$20.3K	29,700
2025-01-15	GRALGRAIL, Inc.A Award	Director	AAward	+1,182 sh	$17.58	+$20.8K	28,916
2024-10-30	GRALGRAIL, Inc.A Award	Director	AAward	+210 sh	$13.62	+$2,860.2	27,734
2024-10-15	GRALGRAIL, Inc.A Award	Director	AAward	+1,054 sh	$14.01	+$14.8K	27,524
2024-06-25	GRALGRAIL, Inc.A Award	Director	AAward	+26.5K sh	—	—	26,470
2024-06-12	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,515
2024-06-12	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+7,737 sh	—	—	26,693
2023-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+1,673 sh	—	—	18,956
2023-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,447 sh	—	—	2,447
2023-04-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+10.5K sh	—	—	17,283
2023-04-14	NTLAIntellia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.9K sh	—	—	14,931
2019-06-26	ABBVAbbVie Inc.P Purchase	EVP, Finance & Administration	PPurchase	+30.4K sh	$67.30	+$2.05M	169,552
2019-02-28	ABBVAbbVie Inc.F Tax Payment	EVP, Finance & Administration	FTax Payment	−27.3K sh	$79.41	−$2.17M	139,152
2019-02-21	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+15.9K sh	—	—	142,958
2019-02-21	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+15K sh	—	—	157,947
2019-02-21	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+8,481 sh	—	—	166,428
2019-02-21	ABBVAbbVie Inc. · Option (right to buy)A Award	EVP, Finance & Administration	AAward	+60.7K sh	—	—	60,747
2019-02-21	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+22.2K sh	—	—	127,013
2018-12-12	ABBVAbbVie Inc.S Sale	EVP, Finance & Administration	SSale	−60K sh	$90.00	−$5.4M	104,863
2018-03-01	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	+13.4K sh	$28.31	+$379K	178,263
2018-03-01	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	+19K sh	$24.21	+$460K	197,263
2018-03-01	ABBVAbbVie Inc.S Sale	EVP, Finance & Administration	SSale	−32.4K sh	$114.50	−$3.71M	164,863
2018-03-01	ABBVAbbVie Inc. · Option (right to buy)M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	−13.4K sh	—	—	0
2018-03-01	ABBVAbbVie Inc. · Option (right to buy)M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	−19K sh	—	—	0
2018-02-28	ABBVAbbVie Inc.S Sale	EVP, Finance & Administration	SSale	−38.5K sh	$119.44	−$4.6M	164,863
2018-02-28	ABBVAbbVie Inc.F Tax Payment	EVP, Finance & Administration	FTax Payment	−28.4K sh	$118.26	−$3.36M	203,391
2018-02-15	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+15.9K sh	—	—	199,488
2018-02-15	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+17.3K sh	—	—	216,807
2018-02-15	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+15K sh	—	—	231,798
2018-02-15	ABBVAbbVie Inc. · Option (right to buy)A Award	EVP, Finance & Administration	AAward	+45.8K sh	—	—	45,840
2017-05-18	ABBVAbbVie Inc. · Option (right to buy)M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	−25.5K sh	—	—	0
2017-05-18	ABBVAbbVie Inc. · Option (right to buy)M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	−12.8K sh	—	—	0
2017-05-18	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	+25.5K sh	$28.86	+$736K	209,043
2017-05-18	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Finance & Administration	MExercise/Conversion	+12.8K sh	$28.13	+$360K	221,843
2017-05-18	ABBVAbbVie Inc.S Sale	EVP, Finance & Administration	SSale	−38.3K sh	$65.35	−$2.5M	183,543
2017-02-28	ABBVAbbVie Inc.F Tax Payment	EVP, Finance & Administration	FTax Payment	−40.2K sh	$62.22	−$2.5M	183,543
2017-02-16	ABBVAbbVie Inc. · Option (right to buy)A Award	EVP, Finance & Administration	AAward	+100K sh	—	—	100,100
2017-02-16	ABBVAbbVie Inc.A Award	EVP, Finance & Administration	AAward	+15.9K sh	—	—	223,755

Recent filings

Accepted (ET)
Jul 164
CHASE WILLIAM J0001628280-26-048488
SEC(opens sec.gov)
Jun 224
CHASE WILLIAM J0001628280-26-044736
SEC(opens sec.gov)
Jun 104
CHASE WILLIAM J0001563572-26-000001
SEC(opens sec.gov)
Apr 174
CHASE WILLIAM J0001628280-26-025730
SEC(opens sec.gov)
Jan 164
CHASE WILLIAM J0001628280-26-002435
SEC(opens sec.gov)
Oct 164
CHASE WILLIAM J0001628280-25-045265
SEC(opens sec.gov)
Aug 224
CHASE WILLIAM J0000950170-25-110979
SEC(opens sec.gov)
Jul 174
CHASE WILLIAM J0001699031-25-000158
SEC(opens sec.gov)
Jun 134
CHASE WILLIAM J0000950170-25-086231
SEC(opens sec.gov)
May 304
CHASE WILLIAM J0001699031-25-000129
SEC(opens sec.gov)
Apr 164
CHASE WILLIAM J0001699031-25-000084
SEC(opens sec.gov)
Jan 164
CHASE WILLIAM J0001628280-25-001746
SEC(opens sec.gov)
Nov 14
CHASE WILLIAM J0001628280-24-044798
SEC(opens sec.gov)
Oct 174
CHASE WILLIAM J0001628280-24-043071
SEC(opens sec.gov)
Jun 274
CHASE WILLIAM J0001628280-24-030363
SEC(opens sec.gov)
Jun 144
CHASE WILLIAM J0000950170-24-073680
SEC(opens sec.gov)
Jun 164
CHASE WILLIAM J0001209191-23-037910
SEC(opens sec.gov)

Companies

Address

C/O GRAIL, INC. 1525 O'BRIEN DRIVE

MENLO PARK, CA, 94025